Identifying Effective Enzyme Activity Targets for Recombinant Class I and Class II Collagenase for Successful Human Islet Isolation

Isolation following a good manufacturing practice-compliant, human islet product requires development of a robust islet isolation procedure where effective limits of key reagents are known. The enzymes used for islet isolation are critical but little is known about the doses of class I and class II...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplantation direct 2016-01, Vol.2 (1), p.e54-e54
Hauptverfasser: Balamurugan, Appakalai N., Green, Michael L., Breite, Andrew G., Loganathan, Gopalakrishnan, Wilhelm, Joshua J., Tweed, Benjamin, Vargova, Lenka, Lockridge, Amber, Kuriti, Manikya, Hughes, Michael G., Williams, Stuart K., Hering, Bernhard J., Dwulet, Francis E., McCarthy, Robert C.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page e54
container_issue 1
container_start_page e54
container_title Transplantation direct
container_volume 2
creator Balamurugan, Appakalai N.
Green, Michael L.
Breite, Andrew G.
Loganathan, Gopalakrishnan
Wilhelm, Joshua J.
Tweed, Benjamin
Vargova, Lenka
Lockridge, Amber
Kuriti, Manikya
Hughes, Michael G.
Williams, Stuart K.
Hering, Bernhard J.
Dwulet, Francis E.
McCarthy, Robert C.
description Isolation following a good manufacturing practice-compliant, human islet product requires development of a robust islet isolation procedure where effective limits of key reagents are known. The enzymes used for islet isolation are critical but little is known about the doses of class I and class II collagenase required for successful islet isolation. We used a factorial approach to evaluate the effect of high and low target activities of recombinant class I (rC1) and class II (rC2) collagenase on human islet yield. Consequently, 4 different enzyme formulations with divergent C1:C2 collagenase mass ratios were assessed, each supplemented with the same dose of neutral protease. Both split pancreas and whole pancreas models were used to test enzyme targets (n = 20). Islet yield/g pancreas was compared with historical enzymes (n = 42). Varying the Wunsch (rC2) and collagen degradation activity (CDA, rC1) target dose, and consequently the C1:C2 mass ratio, had no significant effect on tissue digestion. Digestions using higher doses of Wunsch and CDA resulted in comparable islet yields to those obtained with 60% and 50% of those activities, respectively. Factorial analysis revealed no significant main effect of Wunsch activity or CDA for any parameter measured. Aggregate results from 4 different collagenase formulations gave 44% higher islet yield (>5000 islet equivalents/g) in the body/tail of the pancreas (n = 12) when compared with those from the same segment using a standard natural collagenase/protease mixture (n = 6). Additionally, islet yields greater than 5000 islet equivalents/g pancreas were also obtained in whole human pancreas. A broader C1:C2 ratio can be used for human islet isolation than has been used in the past. Recombinant collagenase is an effective replacement for the natural enzyme and we have determined that high islet yield can be obtained even with low doses of rC1:rC2, which is beneficial for the survival of islets.
doi_str_mv 10.1097/TXD.0000000000000563
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4946501</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1810357266</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5194-75dbac022742cd8082cb11bcbdd6477b9afd0f40042b79f34ea77e4d5e231ba43</originalsourceid><addsrcrecordid>eNpdkUtv1DAUhSMEolXpP0DISzYpfiVONkjVMLSRKlWig8TOcpzrGYNjF9tpNWz7x8n0xVAv7Gv5nO_66hTFe4JPCG7Fp9WPLyd4f1U1e1UcUiZY2QhGXu_VB8VxSj9nDeF1zSl7WxxQUWFMuTgs7roBfLZma_0aLY0Bne0NoKX_sx0Bne5uNm_RSsU15IRMiOgb6DD21iuf0cKplFCHlB-e6g4tgnNqDV4luDdcTVpDSmZy6HwalUddcpDnPTiVbfDvijdGuQTHj-dR8f3rcrU4Ly8uz7rF6UWpK9LyUlRDrzSmVHCqhwY3VPeE9LofhpoL0bfKDNhwjDntRWsYByUE8KECykivODsqPj9wr6d-hEHPg0fl5HW0o4pbGZSV_794u5HrcCN5y-sKkxnw8REQw-8JUpajTRrmaT2EKUnSEMwqQet6lvIHqY4hpQjmuQ3BchehnCOULyOcbR_2v_hsegrsH_c2uAwx_XLTLUS5AeXyRmLS8IrSpqSY1JjM0HJH5uwvqA6o2g</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1810357266</pqid></control><display><type>article</type><title>Identifying Effective Enzyme Activity Targets for Recombinant Class I and Class II Collagenase for Successful Human Islet Isolation</title><source>DOAJ Directory of Open Access Journals</source><source>Journals@Ovid Complete</source><source>Wolters Kluwer Open Health</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Balamurugan, Appakalai N. ; Green, Michael L. ; Breite, Andrew G. ; Loganathan, Gopalakrishnan ; Wilhelm, Joshua J. ; Tweed, Benjamin ; Vargova, Lenka ; Lockridge, Amber ; Kuriti, Manikya ; Hughes, Michael G. ; Williams, Stuart K. ; Hering, Bernhard J. ; Dwulet, Francis E. ; McCarthy, Robert C.</creator><creatorcontrib>Balamurugan, Appakalai N. ; Green, Michael L. ; Breite, Andrew G. ; Loganathan, Gopalakrishnan ; Wilhelm, Joshua J. ; Tweed, Benjamin ; Vargova, Lenka ; Lockridge, Amber ; Kuriti, Manikya ; Hughes, Michael G. ; Williams, Stuart K. ; Hering, Bernhard J. ; Dwulet, Francis E. ; McCarthy, Robert C.</creatorcontrib><description>Isolation following a good manufacturing practice-compliant, human islet product requires development of a robust islet isolation procedure where effective limits of key reagents are known. The enzymes used for islet isolation are critical but little is known about the doses of class I and class II collagenase required for successful islet isolation. We used a factorial approach to evaluate the effect of high and low target activities of recombinant class I (rC1) and class II (rC2) collagenase on human islet yield. Consequently, 4 different enzyme formulations with divergent C1:C2 collagenase mass ratios were assessed, each supplemented with the same dose of neutral protease. Both split pancreas and whole pancreas models were used to test enzyme targets (n = 20). Islet yield/g pancreas was compared with historical enzymes (n = 42). Varying the Wunsch (rC2) and collagen degradation activity (CDA, rC1) target dose, and consequently the C1:C2 mass ratio, had no significant effect on tissue digestion. Digestions using higher doses of Wunsch and CDA resulted in comparable islet yields to those obtained with 60% and 50% of those activities, respectively. Factorial analysis revealed no significant main effect of Wunsch activity or CDA for any parameter measured. Aggregate results from 4 different collagenase formulations gave 44% higher islet yield (&gt;5000 islet equivalents/g) in the body/tail of the pancreas (n = 12) when compared with those from the same segment using a standard natural collagenase/protease mixture (n = 6). Additionally, islet yields greater than 5000 islet equivalents/g pancreas were also obtained in whole human pancreas. A broader C1:C2 ratio can be used for human islet isolation than has been used in the past. Recombinant collagenase is an effective replacement for the natural enzyme and we have determined that high islet yield can be obtained even with low doses of rC1:rC2, which is beneficial for the survival of islets.</description><identifier>ISSN: 2373-8731</identifier><identifier>EISSN: 2373-8731</identifier><identifier>DOI: 10.1097/TXD.0000000000000563</identifier><identifier>PMID: 27500247</identifier><language>eng</language><publisher>United States: The Authors. Published by Wolters Kluwer Health, Inc</publisher><subject>Pancreas and Islet Transplantation</subject><ispartof>Transplantation direct, 2016-01, Vol.2 (1), p.e54-e54</ispartof><rights>The Authors. Published by Wolters Kluwer Health, Inc.</rights><rights>Copyright © 2015 The Authors. Transplantation Direct. Published by Wolters Kluwer Health, Inc. 2015 The Authors. Transplantation Direct. Published by Wolters Kluwer Health, Inc</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5194-75dbac022742cd8082cb11bcbdd6477b9afd0f40042b79f34ea77e4d5e231ba43</citedby><cites>FETCH-LOGICAL-c5194-75dbac022742cd8082cb11bcbdd6477b9afd0f40042b79f34ea77e4d5e231ba43</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946501/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4946501/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27903,27904,53770,53772</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/27500247$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Balamurugan, Appakalai N.</creatorcontrib><creatorcontrib>Green, Michael L.</creatorcontrib><creatorcontrib>Breite, Andrew G.</creatorcontrib><creatorcontrib>Loganathan, Gopalakrishnan</creatorcontrib><creatorcontrib>Wilhelm, Joshua J.</creatorcontrib><creatorcontrib>Tweed, Benjamin</creatorcontrib><creatorcontrib>Vargova, Lenka</creatorcontrib><creatorcontrib>Lockridge, Amber</creatorcontrib><creatorcontrib>Kuriti, Manikya</creatorcontrib><creatorcontrib>Hughes, Michael G.</creatorcontrib><creatorcontrib>Williams, Stuart K.</creatorcontrib><creatorcontrib>Hering, Bernhard J.</creatorcontrib><creatorcontrib>Dwulet, Francis E.</creatorcontrib><creatorcontrib>McCarthy, Robert C.</creatorcontrib><title>Identifying Effective Enzyme Activity Targets for Recombinant Class I and Class II Collagenase for Successful Human Islet Isolation</title><title>Transplantation direct</title><addtitle>Transplant Direct</addtitle><description>Isolation following a good manufacturing practice-compliant, human islet product requires development of a robust islet isolation procedure where effective limits of key reagents are known. The enzymes used for islet isolation are critical but little is known about the doses of class I and class II collagenase required for successful islet isolation. We used a factorial approach to evaluate the effect of high and low target activities of recombinant class I (rC1) and class II (rC2) collagenase on human islet yield. Consequently, 4 different enzyme formulations with divergent C1:C2 collagenase mass ratios were assessed, each supplemented with the same dose of neutral protease. Both split pancreas and whole pancreas models were used to test enzyme targets (n = 20). Islet yield/g pancreas was compared with historical enzymes (n = 42). Varying the Wunsch (rC2) and collagen degradation activity (CDA, rC1) target dose, and consequently the C1:C2 mass ratio, had no significant effect on tissue digestion. Digestions using higher doses of Wunsch and CDA resulted in comparable islet yields to those obtained with 60% and 50% of those activities, respectively. Factorial analysis revealed no significant main effect of Wunsch activity or CDA for any parameter measured. Aggregate results from 4 different collagenase formulations gave 44% higher islet yield (&gt;5000 islet equivalents/g) in the body/tail of the pancreas (n = 12) when compared with those from the same segment using a standard natural collagenase/protease mixture (n = 6). Additionally, islet yields greater than 5000 islet equivalents/g pancreas were also obtained in whole human pancreas. A broader C1:C2 ratio can be used for human islet isolation than has been used in the past. Recombinant collagenase is an effective replacement for the natural enzyme and we have determined that high islet yield can be obtained even with low doses of rC1:rC2, which is beneficial for the survival of islets.</description><subject>Pancreas and Islet Transplantation</subject><issn>2373-8731</issn><issn>2373-8731</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNpdkUtv1DAUhSMEolXpP0DISzYpfiVONkjVMLSRKlWig8TOcpzrGYNjF9tpNWz7x8n0xVAv7Gv5nO_66hTFe4JPCG7Fp9WPLyd4f1U1e1UcUiZY2QhGXu_VB8VxSj9nDeF1zSl7WxxQUWFMuTgs7roBfLZma_0aLY0Bne0NoKX_sx0Bne5uNm_RSsU15IRMiOgb6DD21iuf0cKplFCHlB-e6g4tgnNqDV4luDdcTVpDSmZy6HwalUddcpDnPTiVbfDvijdGuQTHj-dR8f3rcrU4Ly8uz7rF6UWpK9LyUlRDrzSmVHCqhwY3VPeE9LofhpoL0bfKDNhwjDntRWsYByUE8KECykivODsqPj9wr6d-hEHPg0fl5HW0o4pbGZSV_794u5HrcCN5y-sKkxnw8REQw-8JUpajTRrmaT2EKUnSEMwqQet6lvIHqY4hpQjmuQ3BchehnCOULyOcbR_2v_hsegrsH_c2uAwx_XLTLUS5AeXyRmLS8IrSpqSY1JjM0HJH5uwvqA6o2g</recordid><startdate>20160101</startdate><enddate>20160101</enddate><creator>Balamurugan, Appakalai N.</creator><creator>Green, Michael L.</creator><creator>Breite, Andrew G.</creator><creator>Loganathan, Gopalakrishnan</creator><creator>Wilhelm, Joshua J.</creator><creator>Tweed, Benjamin</creator><creator>Vargova, Lenka</creator><creator>Lockridge, Amber</creator><creator>Kuriti, Manikya</creator><creator>Hughes, Michael G.</creator><creator>Williams, Stuart K.</creator><creator>Hering, Bernhard J.</creator><creator>Dwulet, Francis E.</creator><creator>McCarthy, Robert C.</creator><general>The Authors. Published by Wolters Kluwer Health, Inc</general><general>Lippincott Williams &amp; Wilkins</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20160101</creationdate><title>Identifying Effective Enzyme Activity Targets for Recombinant Class I and Class II Collagenase for Successful Human Islet Isolation</title><author>Balamurugan, Appakalai N. ; Green, Michael L. ; Breite, Andrew G. ; Loganathan, Gopalakrishnan ; Wilhelm, Joshua J. ; Tweed, Benjamin ; Vargova, Lenka ; Lockridge, Amber ; Kuriti, Manikya ; Hughes, Michael G. ; Williams, Stuart K. ; Hering, Bernhard J. ; Dwulet, Francis E. ; McCarthy, Robert C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5194-75dbac022742cd8082cb11bcbdd6477b9afd0f40042b79f34ea77e4d5e231ba43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Pancreas and Islet Transplantation</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Balamurugan, Appakalai N.</creatorcontrib><creatorcontrib>Green, Michael L.</creatorcontrib><creatorcontrib>Breite, Andrew G.</creatorcontrib><creatorcontrib>Loganathan, Gopalakrishnan</creatorcontrib><creatorcontrib>Wilhelm, Joshua J.</creatorcontrib><creatorcontrib>Tweed, Benjamin</creatorcontrib><creatorcontrib>Vargova, Lenka</creatorcontrib><creatorcontrib>Lockridge, Amber</creatorcontrib><creatorcontrib>Kuriti, Manikya</creatorcontrib><creatorcontrib>Hughes, Michael G.</creatorcontrib><creatorcontrib>Williams, Stuart K.</creatorcontrib><creatorcontrib>Hering, Bernhard J.</creatorcontrib><creatorcontrib>Dwulet, Francis E.</creatorcontrib><creatorcontrib>McCarthy, Robert C.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Transplantation direct</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Balamurugan, Appakalai N.</au><au>Green, Michael L.</au><au>Breite, Andrew G.</au><au>Loganathan, Gopalakrishnan</au><au>Wilhelm, Joshua J.</au><au>Tweed, Benjamin</au><au>Vargova, Lenka</au><au>Lockridge, Amber</au><au>Kuriti, Manikya</au><au>Hughes, Michael G.</au><au>Williams, Stuart K.</au><au>Hering, Bernhard J.</au><au>Dwulet, Francis E.</au><au>McCarthy, Robert C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identifying Effective Enzyme Activity Targets for Recombinant Class I and Class II Collagenase for Successful Human Islet Isolation</atitle><jtitle>Transplantation direct</jtitle><addtitle>Transplant Direct</addtitle><date>2016-01-01</date><risdate>2016</risdate><volume>2</volume><issue>1</issue><spage>e54</spage><epage>e54</epage><pages>e54-e54</pages><issn>2373-8731</issn><eissn>2373-8731</eissn><abstract>Isolation following a good manufacturing practice-compliant, human islet product requires development of a robust islet isolation procedure where effective limits of key reagents are known. The enzymes used for islet isolation are critical but little is known about the doses of class I and class II collagenase required for successful islet isolation. We used a factorial approach to evaluate the effect of high and low target activities of recombinant class I (rC1) and class II (rC2) collagenase on human islet yield. Consequently, 4 different enzyme formulations with divergent C1:C2 collagenase mass ratios were assessed, each supplemented with the same dose of neutral protease. Both split pancreas and whole pancreas models were used to test enzyme targets (n = 20). Islet yield/g pancreas was compared with historical enzymes (n = 42). Varying the Wunsch (rC2) and collagen degradation activity (CDA, rC1) target dose, and consequently the C1:C2 mass ratio, had no significant effect on tissue digestion. Digestions using higher doses of Wunsch and CDA resulted in comparable islet yields to those obtained with 60% and 50% of those activities, respectively. Factorial analysis revealed no significant main effect of Wunsch activity or CDA for any parameter measured. Aggregate results from 4 different collagenase formulations gave 44% higher islet yield (&gt;5000 islet equivalents/g) in the body/tail of the pancreas (n = 12) when compared with those from the same segment using a standard natural collagenase/protease mixture (n = 6). Additionally, islet yields greater than 5000 islet equivalents/g pancreas were also obtained in whole human pancreas. A broader C1:C2 ratio can be used for human islet isolation than has been used in the past. Recombinant collagenase is an effective replacement for the natural enzyme and we have determined that high islet yield can be obtained even with low doses of rC1:rC2, which is beneficial for the survival of islets.</abstract><cop>United States</cop><pub>The Authors. Published by Wolters Kluwer Health, Inc</pub><pmid>27500247</pmid><doi>10.1097/TXD.0000000000000563</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2373-8731
ispartof Transplantation direct, 2016-01, Vol.2 (1), p.e54-e54
issn 2373-8731
2373-8731
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4946501
source DOAJ Directory of Open Access Journals; Journals@Ovid Complete; Wolters Kluwer Open Health; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Pancreas and Islet Transplantation
title Identifying Effective Enzyme Activity Targets for Recombinant Class I and Class II Collagenase for Successful Human Islet Isolation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T05%3A50%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identifying%20Effective%20Enzyme%20Activity%20Targets%20for%20Recombinant%20Class%20I%20and%20Class%20II%20Collagenase%20for%20Successful%20Human%20Islet%20Isolation&rft.jtitle=Transplantation%20direct&rft.au=Balamurugan,%20Appakalai%20N.&rft.date=2016-01-01&rft.volume=2&rft.issue=1&rft.spage=e54&rft.epage=e54&rft.pages=e54-e54&rft.issn=2373-8731&rft.eissn=2373-8731&rft_id=info:doi/10.1097/TXD.0000000000000563&rft_dat=%3Cproquest_pubme%3E1810357266%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1810357266&rft_id=info:pmid/27500247&rfr_iscdi=true